Longevity Breakthroughs: Rapamycin, Senolytics & AI - Immortality Update!

This week's Immortality Update reveals cutting-edge longevity breakthroughs! Discover how to extend your healthspan and improve quality of life with the latest in geroscience. We're diving into revolutionary longevity drugs, new aging measurement technologies, and the ethics of rapid progress in lifespan extension. Learn about rapamycin, senolytics, spatial aging clocks, and AI's role in drug discovery. Watch now to stay informed about the future of aging! Key Takeaways: - Rapamycin: Confirmed as a top caloric restriction mimetic, surpassing metformin in lifespan extension. - Precision Senolytics: Targeted removal of senescent cells shows promise in treating liver disease. - Spatial Aging Clocks: High-resolution maps of aging within tissues reveal the importance of cellular neighborhoods. - Genetic Reprogramming: Demonstrates significant lifespan extension in yeast cells through dynamic modulation of aging pathways. - AI-Powered Platforms: Accelerating drug discovery with reliable human-organoid model preclinical testing. About the Research: This update synthesizes findings from recent research papers and industry announcements, providing a clear overview of impactful geroscience developments. We analyze new interventions, clinical trial progress, and ethical considerations in extending healthspan. #longevity #healthspan #aging #geroscience #rapamycin #senolytics #AI #biotech #research #biomarkers #lifespan #agingresearch #healthyliving #science #innovation Chapters: 00:00:00 - Intro 00:01:30 - The Great Recalibration in Longevity Drugs 00:02:18 - Rapamycin vs. Metformin 00:04:03 - The Safety of Rapamycin 00:05:16 - Targeting Zombie Cells with Senolytics 00:07:45 - Measuring Aging with Spatial Geromics 00:09:34 - Genetic Reprogramming 00:10:49 - The Role of AI in Drug Discovery 00:11:43 - Human-Organoid Platforms 00:13:21 - Equity Imperative 00:14:24 - Regulatory Bottleneck